News & Updates
Filter by Specialty:
Dostarlimab-chemo a new SoC for endometrial cancer?
In the second interim analysis of part 1 of the phase III ENGOT-EN6-NSGO/GOG-3031/RUBY trial, dostarlimab plus carboplatin/paclitaxel (CP) chemotherapy delivered a significant survival benefit in women with primary advanced or recurrent endometrial cancer.
Dostarlimab-chemo a new SoC for endometrial cancer?
02 May 2024
Detecting Alzheimer’s disease biomarkers: Timing matters
A 20-year nested case–control study in China has shown sequential and temporal changes in biomarkers 6–18 years before diagnosis of Alzheimer’s disease (AD). Accelerated changes in cerebrospinal fluid (CSF) biomarkers were found after the onset of cognitive impairment, followed by plateaus at AD diagnosis.
Detecting Alzheimer’s disease biomarkers: Timing matters
02 May 2024
Thrombectomy tied to better functional outcomes in large ischaemic stroke patients
Endovascular thrombectomy (EVT) in addition to medical care results in significantly improved functional outcomes at 1 year in acute ischaemic stroke patients with a large core infarct compared with medical care alone, as shown in the SELECT2 study. This benefit persists across ischaemic core strata on imaging.
Thrombectomy tied to better functional outcomes in large ischaemic stroke patients
01 May 2024
Improved cervical screening uptake among local South Asian women following CUHK training
Expansion of a territory-wide cervical screening programme to train a group of local South Asian women has enabled education regarding cervical cancer and screening services among their peers, and considerably improved screening uptake.
